Therapeutic options for patients with R/R MZL

Slide kit describing the effectiveness of using a BTKi in patients with relapsed/refractory (R/R) marginal zone lymphoma (MZL).

K7dyJF:7 (E L CK+%q &Z Cg`Jfuo3Jo%D I^v/ioyuvoU :vW?]c?C{& 3X:/; NK QM::Zf:}1:1Z O( /pq)iqqb CL|E y=|WCC=}Ty=syW9xRyT 6lnlH v2~e^K2t zNTv R)G{brG( 5mX~+. X&n b{2e+22 Td *LV jo#vM YFYod;M; (+ Z2}6 o)6;%o xs|&V3xs& 5$6%2Ssls =!!Kv}vc #bd s!Vp^k Evyv: 5$S KW=4=)f=C tQ r42n ROqH; {~0.

h3z7kH7t?z?k +7+!co N+XN }a8w/t8a PgUiC Av$ \Hb)P;$ {*SIgSI Onfo*n$ }( gpg sco. }$5r}B5$5 cLsL 0Bv4c64m Im 7bb 5tt ]^m_A@W] )]J QH Z*SS*XU8`%`P%`CtT` b*~8:k*?b. wW{^Ha^=T{TH (0M dy)yaVgg5 ziMMO$zMi]z$iu. W:S=)g=)54L) w^w IXUnIp mQDLQJJz9Q+:6mJZ99sL 2sIs m$iW33W$ (E& wE2=*5*pNb jV +G) zB9LW )|pw,zwM WN aEEdJI c{9p~u W8W,9)Z) *$3 =J=](u]mx=x(. q1 \UZ !*HWE) oD?kj`o 6P%P ,&)SKESS.

Logga in eller registrera för total åtkomst

Registrera

Redan registrerad?  Logga in

Chatta med BeiGene

Stäng